Evolving concepts of apoptosis in idiopathic pulmonary fibrosis
- PMID: 16738200
- PMCID: PMC2231523
- DOI: 10.1513/pats.200601-001TK
Evolving concepts of apoptosis in idiopathic pulmonary fibrosis
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic, relentlessly progressive fibrosing disease of the lung of unknown etiology. Significant progress has been made in recent years in elucidating key aspects of the pathobiology of IPF. Insights into disease pathogenesis have come from studies of cell biology, growth factor/cytokine signaling, animal models of pulmonary fibrosis, and human IPF cells and tissue. A consistent finding in the ultrastructural pathology of IPF is alveolar epithelial cell injury and apoptosis. Another consistent finding in the histopathology of human IPF, described as usual interstitial pneumonia, is the accumulation of aggregates of myofibroblasts in fibroblastic foci. The extent or profusion of fibroblastic foci in lung biopsies is strongly correlated with increased mortality in patients with IPF. There is emerging evidence that myofibroblasts in IPF/usual interstitial pneumonia, both in the in vivo microenvironment and during the process of differentiation in vitro, acquire resistance to apoptosis. Here, we review the current evidence and mechanisms for this apparent "apoptosis paradox" in the pathogenesis of IPF.
Figures
![<b>Figure 1.</b>](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2658687/bin/PROCATS34350fig1.gif)
![<b>Figure 2.</b>](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/2658687/bin/PROCATS34350fig2.gif)
Similar articles
-
Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers.Proc Am Thorac Soc. 2006 Jun;3(4):364-72. doi: 10.1513/pats.200601-003TK. Proc Am Thorac Soc. 2006. PMID: 16738202 Review.
-
Usual interstitial pneumonia and smoking-related interstitial fibrosis display epithelial to mesenchymal transition in fibroblastic foci.Respir Med. 2014 Sep;108(9):1377-86. doi: 10.1016/j.rmed.2014.06.008. Epub 2014 Jul 17. Respir Med. 2014. PMID: 25066934
-
Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.Am J Respir Cell Mol Biol. 2010 May;42(5):626-32. doi: 10.1165/rcmb.2009-0021OC. Epub 2009 Jul 13. Am J Respir Cell Mol Biol. 2010. PMID: 19597127
-
Pathogenetic pathways and novel pharmacotherapeutic targets in idiopathic pulmonary fibrosis.Pulm Pharmacol Ther. 2007;20(5):453-61. doi: 10.1016/j.pupt.2006.01.002. Epub 2006 Mar 3. Pulm Pharmacol Ther. 2007. PMID: 16516512 Review.
-
[Idiopathic pulmonary fibrosis].Vnitr Lek. 2005 Dec;51(12):1375-84. Vnitr Lek. 2005. PMID: 16430105 Review. Czech.
Cited by
-
Pazopanib attenuated bleomycin-induced pulmonary fibrosis via suppressing TGF-β1 signaling pathway.J Thorac Dis. 2024 Apr 30;16(4):2244-2258. doi: 10.21037/jtd-23-1349. Epub 2024 Apr 16. J Thorac Dis. 2024. PMID: 38738240 Free PMC article.
-
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.
-
TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT).J Clin Med. 2024 Feb 19;13(4):1160. doi: 10.3390/jcm13041160. J Clin Med. 2024. PMID: 38398472 Free PMC article.
-
The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives.Int J Mol Sci. 2023 Dec 31;25(1):547. doi: 10.3390/ijms25010547. Int J Mol Sci. 2023. PMID: 38203718 Free PMC article. Review.
-
In vitro co-culture studies and the crucial role of fibroblast-immune cell crosstalk in IPF pathogenesis.Respir Res. 2023 Nov 27;24(1):298. doi: 10.1186/s12931-023-02608-x. Respir Res. 2023. PMID: 38012580 Free PMC article. Review.
References
-
- Thannickal VJ, Toews GB, White ES, Lynch JP, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med 2004;55:395–417. - PubMed
-
- Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136–151. - PubMed
-
- Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000;69:217–245. - PubMed
-
- Yan N, Shi Y. Mechanisms of apoptosis through structural biology. Annu Rev Cell Dev Biol 2005;21:35–56. - PubMed
-
- Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004;116:205–219. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical